These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 29120233)

  • 1. Development of a high-performance, enterprise-level, multimode LC-MS/MS autosampler for drug discovery.
    Kapinos B; Liu J; Piotrowski M; Keefer J; Holder B; Janiszewski J; Zhang H; Troutman M
    Bioanalysis; 2017 Nov; 9(21):1643-1654. PubMed ID: 29120233
    [No Abstract]   [Full Text] [Related]  

  • 2. Hydrophilic interaction liquid chromatography-tandem mass spectrometry for drug development.
    Hsieh Y
    Curr Drug Discov Technol; 2010 Sep; 7(3):223-31. PubMed ID: 20843291
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic stability screen for drug discovery using cassette analysis and column switching.
    Halladay JS; Wong S; Jaffer SM; Sinhababu AK; Khojasteh-Bakht SC
    Drug Metab Lett; 2007 Jan; 1(1):67-72. PubMed ID: 19356021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Application of on-line nano-liquid chromatography/mass spectrometry in metabolite identification studies.
    Liu J; Zhao Z; Teffera Y
    Rapid Commun Mass Spectrom; 2012 Feb; 26(3):320-6. PubMed ID: 22223319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mass spectrometric techniques for label-free high-throughput screening in drug discovery.
    Roddy TP; Horvath CR; Stout SJ; Kenney KL; Ho PI; Zhang JH; Vickers C; Kaushik V; Hubbard B; Wang YK
    Anal Chem; 2007 Nov; 79(21):8207-13. PubMed ID: 17902631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A high throughput metabolic stability screening workflow with automated assessment of data quality in pharmaceutical industry.
    Xu R; Manuel M; Cramlett J; Kassel DB
    J Chromatogr A; 2010 Mar; 1217(10):1616-25. PubMed ID: 20132940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Simultaneous determination of three anticonvulsants using hydrophilic interaction LC-MS.
    Oertel R; Arenz N; Pietsch J; Kirch W
    J Sep Sci; 2009 Jan; 32(2):238-43. PubMed ID: 19072899
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential of HILIC-MS in quantitative bioanalysis of drugs and drug metabolites.
    Hsieh Y
    J Sep Sci; 2008 May; 31(9):1481-91. PubMed ID: 18428187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Application of Cassette Ultracentrifugation Using Non-labeled Compounds and Liquid Chromatography-Tandem Mass Spectrometry Analysis for High-Throughput Protein Binding Determination.
    Kieltyka K; McAuliffe B; Cianci C; Drexler DM; Shou W; Zhang J
    J Pharm Sci; 2016 Mar; 105(3):1036-42. PubMed ID: 26886323
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Biotransformation of gabapentin in surface water matrices under different redox conditions and the occurrence of one major TP in the aquatic environment.
    Henning N; Kunkel U; Wick A; Ternes TA
    Water Res; 2018 Jun; 137():290-300. PubMed ID: 29554533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Addressing the analytical throughput challenges in ADME screening using rapid ultra-performance liquid chromatography/tandem mass spectrometry methodologies.
    Plumb RS; Potts WB; Rainville PD; Alden PG; Shave DH; Baynham G; Mazzeo JR
    Rapid Commun Mass Spectrom; 2008 Jul; 22(14):2139-52. PubMed ID: 18543375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and validation of a stability-indicating RP-HPL C-CAD method for gabapentin and its related impurities in presence of degradation products.
    Ragham PK; Chandrasekhar KB
    J Pharm Biomed Anal; 2016 Jun; 125():122-9. PubMed ID: 27018505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of two aerosol-based detectors for the analysis of gabapentin in pharmaceutical formulations by hydrophilic interaction chromatography.
    Jia S; Park JH; Lee J; Kwon SW
    Talanta; 2011 Oct; 85(5):2301-6. PubMed ID: 21962646
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of a selection of anti-epileptic drugs and two active metabolites in whole blood by reversed phase UPLC-MS/MS and some examples of application of the method in forensic toxicology cases.
    Karinen R; Vindenes V; Hasvold I; Olsen KM; Christophersen AS; Øiestad E
    Drug Test Anal; 2015 Jul; 7(7):634-44. PubMed ID: 25331692
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of two modified quick, easy, cheap, effective, rugged and safe (QuEChERS) sample preparation methods for the analysis of baclofen and gabapentin in feeds by liquid chromatography tandem mass spectrometry.
    Hou XL; Wu YL; Chen RX; Zhu Y; Lv Y; Xu XQ
    J Pharm Biomed Anal; 2014 Jan; 88():53-9. PubMed ID: 24036362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a validated RP-LC/ESI-MS-MS method for separation, identification and determination of related substances of tamsulosin in bulk drugs and formulations.
    Nageswara Rao R; Kumar Talluri MV; Narasa Raju A; Shinde DD; Ramanjaneyulu GS
    J Pharm Biomed Anal; 2008 Jan; 46(1):94-103. PubMed ID: 17951020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Developing a cassette microdosing approach to enhance the throughput of PET imaging agent screening.
    Xiao H; Sun M; Zhao R; Hong H; Zhang A; Zhang S; Liu F; Zhang Y; Liu Y; Zhu L; Kung HF; Qiao J
    J Pharm Biomed Anal; 2018 May; 154():48-56. PubMed ID: 29533858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel LC-MS approach for the detection of metabolites in DMPK studies.
    Plumb RS; Mather J; Little D; Rainville PD; Twohig M; Harland G; Kenny DJ; Nicholson JK; Wilson ID; Kass IJ
    Bioanalysis; 2010 Oct; 2(10):1767-78. PubMed ID: 21083328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased productivity in quantitative bioanalysis using a monolithic column coupled with high-flow direct-injection liquid chromatography/tandem mass spectrometry.
    Huang MQ; Mao Y; Jemal M; Arnold M
    Rapid Commun Mass Spectrom; 2006; 20(11):1709-14. PubMed ID: 16676309
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The use of partially porous particle columns for the routine, generic analysis of biological samples for pharmacokinetic studies in drug discovery by reversed-phase ultra-high performance liquid chromatography-tandem mass spectrometry.
    Mallett DN; Ramírez-Molina C
    J Pharm Biomed Anal; 2009 Jan; 49(1):100-7. PubMed ID: 19019615
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.